The first is to increase tumor oxygen levels, which can be achieved by inducing angiogenesis and erythropoiesis through the transcription of proangiogenic genes, such as vascular endothelial growth factor (VEGF) and erythropoietin (EPO) [64,65]. The gene discussed is EPO; the disease is neoplasm.